# A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

> **NCT00992654** · — · NO_LONGER_AVAILABLE · sponsor: **ViiV Healthcare**

## Conditions studied

- Human Immunodeficiency Virus (HIV)

## Interventions

- **DRUG:** Open Label Treatment Access: Maraviroc

## Key facts

- **NCT ID:** NCT00992654
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00992654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00992654, "A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00992654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*